In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression.
Matt Argersinger, senior advisor for Motley Fool Millionacres, joins us to talk about how Covid-19 has impacted residential and commercial real estate and offers his advice for homeowners and investors going forward.
Microsoft buys Nuance Communications in a $16 billion deal. Coinbase makes an $86 billion Wall Street debut. FDA hits the pause button on Johnson & Johnson’s COVID-19 vaccine. Katrina Lake steps down as the CEO of Stitch Fix. Bed Bath & Beyond slips on earnings. White Claw introduces Surge. Pepsi serves up big growth in its snack division. And IBM unveils a surprising name for its cloud business. Motley Fool analysts Emily Flippen and Ron Gross discuss those stories and share two stocks on their radar: Bilibili and Ecolab. Plus, e.l.f. Beauty CFO Mandy Fields talks about the big business of cosmetics.
Today we review 5 Stocks for the Coronavirus, 5 Stocks For The Age of Miracles, and 5 Stocks I Own That You Should Too. Spoiler alert: one of these is not like the others! But do we beat the efficient market? Yes. Indeed we do.